An Overview of the HRD Testing Landscape
Online
30 August, 2023
1:00 pm-2:00 pm (GMT+1)
Poly (ADP-ribose) polymerase inhibitors (PARPi) has emerged as the greatest game-changer in the treatment of ovarian cancer. As HRD-positive (Homologous recombination deficiency) tumors are more sensitive to PARPi, HRD testing identifies advanced ovarian cancer (AOC) patients who will benefit most from PARPi treatment. Thus, a reliable HRD testing with accurate, actionable results is an important first step to guide informed targeted treatment and improve health outcomes for AOC patients.
Join Dr. Pantelis Constantoulakis, Scientific Director and Chief Genetic Officer of Genotypos Science Labs, in this webinar as he will shed light on the landscape of HRD testing, existing commercial HRD solutions, and real-world clinical concordance data.
Join Dr. Pantelis Constantoulakis, Scientific Director and Chief Genetic Officer of Genotypos Science Labs, in this webinar as he will shed light on the landscape of HRD testing, existing commercial HRD solutions, and real-world clinical concordance data.
What will you learn?
The commercial and practical landscape of HRD testingThe best practice recommendations for testing algorithms and interpretation
The latest clinical concordance data of AmoyDx HRD solution
The factors and limitations that might affect the accuracy and reproducibility of HRD measurements.
Featured Speakers
Dr. Pantelis Constantoulakis
Co-founder, Scientific Director and Chief Genetic Officer, Genotypos Science Labs
Pantelis Constantoulakis is the Co-founder, Scientific Director and Chief Genetic Officer of Genotypos Science Labs. He has a Ph.D. from the University of Athens, Greece, and the University of Washington, Seattle, USA. In 1993, Pantelis completed his first post-doctoral fellowship program in Medical Genetics at the University of Washington, and in 1996 his second post-doctoral fellowship program in Human Retrovirus Research at ABL-NCI-Frederic Cancer Research and Development Center. From 1997 to 2015, he founded and directed the first Molecular Genetics Laboratory in Athens, Greece (LOCUS VITAE-LOCUS MEDICUS) and since then he is directing Genotypos MSA.
He has published over 50 peer-reviewed articles in scientific journals in the above fields, has been an invited speaker on topics of his expertise at congresses, and an invited lecturer on genetic diagnosis at the University of Athens and the University of Thraki.